ENAVATE SCIENCES GP, LLC
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1953107
New York, NY
Position in BBOT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,511,166
-$9,378,197 QoQ
Shares Held
2,626,946
0.0% QoQ
Ownership
3.28%
of shares outstanding
% of Portfolio
6.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBOT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENAVATE SCIENCES GP, LLC holds $351,507,327 across 7 Biotechnology names. BBOT ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SION |
Sionna Therapeutics, Inc.
|
2,478,030 | $99,344,222 | |
| 2 | IMNM |
Immunome Inc.
|
3,613,799 | $79,033,784 | |
| 3 | ZBIO |
Zenas BioPharma, Inc.
|
3,919,159 | $76,619,558 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
7,788,150 | $41,199,313 | |
| 5 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
This page
|
2,626,946 | $23,511,166 | |
| 6 | UPB |
Upstream Bio, Inc.
|
2,459,703 | $22,137,327 | |
| 7 | CAMP |
Camp4 Therapeutics Corp
|
2,190,920 | $9,661,957 |
All Filings in BBOT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,511,166 | 2,626,946 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,889,363 | 2,626,946 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,420,034 | 2,626,946 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||